ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	21/151	191/7206	3.36928506747e-10
ko05164	Influenza A	15/151	167/7206	1.86548209882e-06
ko04621	NOD-like receptor signaling pathway	14/151	157/7206	4.56286691663e-06
ko05321	Inflammatory bowel disease (IBD)	8/151	56/7206	1.87095099715e-05
ko04380	Osteoclast differentiation	12/151	134/7206	2.16356567425e-05
ko04658	Th1 and Th2 cell differentiation	10/151	96/7206	2.92015956207e-05
ko04650	Natural killer cell mediated cytotoxicity	10/151	97/7206	3.19804121598e-05
ko05162	Measles	11/151	120/7206	3.87964335756e-05
ko05340	Primary immunodeficiency	5/151	30/7206	0.000352902776809
ko04630	Jak-STAT signaling pathway	10/151	132/7206	0.000424442882672
ko05152	Tuberculosis	12/151	187/7206	0.000527051729396
ko05150	Staphylococcus aureus infection	5/151	36/7206	0.000843806795582
ko04672	Intestinal immune network for IgA production	5/151	37/7206	0.000959373026922
ko04217	Necroptosis	11/151	178/7206	0.00122768238295
ko04610	Complement and coagulation cascades	7/151	79/7206	0.0012667697747
ko05168	Herpes simplex infection	11/151	182/7206	0.0014697622593
ko05323	Rheumatoid arthritis	7/151	89/7206	0.00253065569095
ko04064	NF-kappa B signaling pathway	7/151	96/7206	0.00387720037028
ko04620	Toll-like receptor signaling pathway	7/151	100/7206	0.00485861696004
ko05167	Kaposi's sarcoma-associated herpesvirus infection	10/151	191/7206	0.00667087292291
ko04611	Platelet activation	9/151	163/7206	0.00708863336705
ko00120	Primary bile acid biosynthesis	3/151	20/7206	0.00791551742972
ko04622	RIG-I-like receptor signaling pathway	5/151	62/7206	0.00937550485459
ko05166	HTLV-I infection	13/151	292/7206	0.00989835111153
ko05144	Malaria	4/151	45/7206	0.0141824413465
ko04660	T cell receptor signaling pathway	7/151	124/7206	0.0151030768928
ko05142	Chagas disease (American trypanosomiasis)	7/151	130/7206	0.0191203516989
ko05320	Autoimmune thyroid disease	3/151	29/7206	0.0221255283036
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/151	135/7206	0.0229986393437
ko04659	Th17 cell differentiation	6/151	106/7206	0.0235386627996
ko04512	ECM-receptor interaction	5/151	79/7206	0.0246462311515
ko05161	Hepatitis B	8/151	173/7206	0.0286103787178
ko00760	Nicotinate and nicotinamide metabolism	3/151	34/7206	0.0335996471057
ko04080	Neuroactive ligand-receptor interaction	3/151	423/7206	0.0350189392787
ko04662	B cell receptor signaling pathway	5/151	88/7206	0.036952059918
ko04668	TNF signaling pathway	6/151	120/7206	0.0398391792067
ko04330	Notch signaling pathway	4/151	62/7206	0.0404978600121
ko05160	Hepatitis C	7/151	153/7206	0.0413965079211
ko05310	Asthma	2/151	17/7206	0.0482939303499
ko05145	Toxoplasmosis	6/151	126/7206	0.0485887611421